Tag: antiviral
Supply for Antiviral Remdesivir is Meeting U.S. Demands
Beginning October 1, Gilead will be responsible for distributing Veklury in the United States upon conclusion of the previous distribution agreement with the U.S. Federal government.
Antiviral Remdesivir Approved for Earlier Use For COVID-19 Patients
Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
NIH: Testing Remdesivir Plus Interferon Beta 1a for COVID-19 Treatment
Infected cells normally produce type 1 interferons to help the immune system fight pathogens, especially viruses. Interferon beta has both antiviral and anti-inflammatory properties.
Merck Developing Two Different COVID-19 Vaccines and Antiviral
According to the World Health Organization’s latest table of COVID-19 vaccines, 124 candidates are at various stages of development with eight different technologies, or platforms.